Market Overview

Stocks Hitting 52-Week Lows

Share:
Related MDCO
Citi Sees Limited Sales For Blood-Clot Drug At The Medicines Company
FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor
Related NRX
NephroGenex Announces Data on Acute Kidney Injury at National Kidney Foundation 2015 Spring Clinical Meetings
Morning Market Gainers

The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

NephroGenex (NASDAQ: NRX) shares reached a new 52-week low of $6.67. On Monday, NephroGenex posted a full-year net loss of $6.3 million, or $19.71 per share.

Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.

Akers Biosciences (NASDAQ: AKER) shares reached a new 52-week low of $3.85. Akers Biosciences' trailing-twelve-month ROE is -41.12%.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

 

Related Articles (BPTH + AKER)

Around the Web, We're Loving...